CGON
CG Oncology, Inc. Common stock
NASDAQ · Healthcare · Biotechnology · US
$74.67
+0.46%1
Insider buys (3m)
6
Insider sells (3m)
$22.1M
Net value (3m)
+37.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | POST LEONARD E · director | M-Exempt | 1,000 | $0.60 |
| Aug 18, 2026 | POST LEONARD E · director | Sale | 1,000 | $75 |
| Jul 17, 2026 | POST LEONARD E · director | Sale | 1,000 | $71 |
| Jul 17, 2026 | POST LEONARD E · director | M-Exempt | 1,000 | $0.60 |
| Jul 14, 2026 | Mulay James · director | Sale | 24,165 | $75 |
| Jul 14, 2026 | Mulay James · director | M-Exempt | 24,165 | $27 |
| Jun 29, 2026 | Liu Brian Guan-Chyun · director | Purchase | 371,085 | $67 |
| Jun 25, 2026 | POST LEONARD E · director | M-Exempt | 5,000 | $0.60 |
| Jun 25, 2026 | POST LEONARD E · director | Sale | 5,000 | $70 |
| Jun 23, 2026 | POST LEONARD E · director | M-Exempt | 5,000 | $0.60 |
| Jun 23, 2026 | POST LEONARD E · director | Sale | 5,000 | $65 |
| Jun 16, 2026 | Mulay James · director | M-Exempt | 1,310 | $13 |
| Jun 16, 2026 | Mulay James · director | Sale | 1,310 | $60 |
| Jun 16, 2026 | Mulay James · director | M-Exempt | 654 | $3.72 |
| Jun 5, 2026 | POST LEONARD E · director | Sale | 1,000 | $55 |
| Jun 5, 2026 | POST LEONARD E · director | M-Exempt | 1,000 | $0.60 |
| Jun 5, 2026 | Mulay James · director | A-Award | 9,354 | $56 |
| Jun 5, 2026 | Tong Victor Edward Jr · director | A-Award | 9,354 | $56 |
| Jun 5, 2026 | Liu Brian Guan-Chyun · director | A-Award | 9,354 | $56 |
| Jun 5, 2026 | Graf Susan E · director | A-Award | 9,354 | $56 |
| Jun 5, 2026 | POST LEONARD E · director | A-Award | 9,354 | $56 |
| Jun 5, 2026 | Rossi Christina · director | A-Award | 9,354 | $56 |
| Apr 20, 2026 | Mulay James · director | M-Exempt | 15,600 | $37 |
| Apr 20, 2026 | Mulay James · director | Sale | 15,600 | $73 |
| Apr 16, 2026 | Kasturi Vijay · officer: Chief Medical Officer | A-Award | 79,216 | $68 |
| Apr 16, 2026 | Kuan Arthur · director, officer: Chief Executive Officer | A-Award | 271,600 | $68 |
| Apr 16, 2026 | DETORE JAMES M. · officer: Chief Financial Officer | A-Award | 90,574 | $68 |
| Apr 16, 2026 | Patterson Joshua F. · officer: See Remarks | A-Award | 45,266 | $68 |
| Apr 16, 2026 | Bellete Ambaw · officer: President and COO | A-Award | 107,508 | $68 |
| Mar 17, 2026 | Mulay James · director | Sale | 1,310 | $64 |
Institutional positioning
13F filings over the trailing two quarters
New 103Increased 180Reduced 138Sold out 38
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RTW INVESTMENTS, LP | Increased | 8,514,590 | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Increased | 6,984,808 | May 15, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 6,720,389 | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 6,616,899 | Aug 14, 2026 |
| Decheng Capital LLC | Unchanged | 6,371,669 | Aug 14, 2026 |
| DECHENG CAPITAL LLC | Unchanged | 6,371,669 | May 13, 2026 |
| BlackRock, Inc. | Increased | 6,256,288 | Aug 7, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 5,371,232 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 5,324,751 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 5,064,180 | May 13, 2026 |
| FMR LLC | Increased | 4,161,493 | Aug 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 3,805,010 | Aug 14, 2026 |
| FMR LLC | Reduced | 3,764,844 | May 15, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Unchanged | 3,670,206 | May 15, 2026 |
| TCG Crossover Management, LLC | Unchanged | 3,670,206 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026